Advocacy

Virtual Advocacy Day set for May 20, Launch of New Programs, and More

The Network celebrates its 35th anniversary with a virtual Capitol Hill day, launch of new programs, more.
Step Therapy Policies For Asthma and Allergies Are Failing Patients

The Network advocates against step therapy which limits patient treatment options, and can be dangerous and time-consuming. Learn what you can do about it.
A Recap of Asthma Funding in 2020 Budget

News regarding the Allergy & Asthma Network’s successful advocacy efforts leading to increases in federal program funding and policy provisions.
Joint Statement on Peanut Allergy Therapy Review

The Network joins other patient organizations to urge ICER to consider patient needs when determining the value of emerging treatments for peanut allergy.
House Majority Leader Steny Hoyer Introduces School-Based Allergy and Asthma Management Legislation at AADCH

The Network’s 2019 Allergy and Asthma Day on Capitol Hill event connects advocates and legislators to drive change on key asthma and allergy issues.
Patient Advocates, Medical Professionals and Industry Stakeholders Unite to Curb Oral Corticosteroid Overexposure in Asthma Treatment

The Network announces a new campaign to raise awareness about the risks of oral corticosteroid overuse and its adverse impact on people with asthma.
FDA Decision to OK Primatene Mist Endangers Asthma Patients

The Network joins other advocacy organizations to express concern over the FDA’s approval of Primatene Mist(R) as treatment for mild, intermittent asthma.
Statement on FDA Decision to Approve OTC Primatene Mist

The Network makes its own statement of concern regarding the FDA approval of Primatine Mist(R) as an over-the-counter treatment for asthma.
‘We Called Him Itty’ – But He Had Big Dreams

Izaiah Fiedler tragically died from suicide whilte on montelukast for asthma. His family now advocates for improved asthma care and suicide prevention.
Statement On Possible Shortage of Epinephrine Auto-Injectors

Read the statement from Allergy & Asthma Network President and CEO on the possible shortage of EpiPens and Adrenaclick epinephrine auto-injectors.
Leading Patient Advocacy Organizations Join Forces to Launch Program Aimed at Raising Awareness of Severe Asthma

Allergy & Asthma Network (AAN) and the Asthma and Allergy Foundation of America (AAFA) today announced the launch of Be the Boss of Your Asthma,…
Taking Flight: Why Epi Auto-Injectors Are Critical on Airlines

One family’s terrifying allergy experience on a plane takes them to Capitol Hill as advocates.

All About

Advocacy

Allergy & Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient’s voice is heard in legislation and policy issues is an important part of the Network’s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care. The COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the “Preserving Patient Savings on Drug Costs Act.” This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.